Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.42% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$184B
| $2.04B | 2.4% |
36,767,942
-1,465,800
| -4% | -$75.2M |
2013 Q2
35 quarters
|
|
|
2
Tesla
TSLA
$1.54T
| $1.68B | 1.97% |
4,666,125
+2,435,700
| +109% | +$759M |
2018 Q4
13 quarters
|
|
3
Kroger
KR
$41.8B
| $942M | 1.11% |
16,427,510
-1,222,800
| -7% | -$60.7M |
2019 Q2
11 quarters
|
|
4
Gilead Sciences
GILD
$208B
| $921M | 1.08% |
15,492,116
+6,410,047
| +71% | +$410M |
2014 Q4
29 quarters
|
|
5
VeriSign
VRSN
$28.1B
| $894M | 1.05% |
4,016,590
-133,300
| -3% | -$29.1M |
2013 Q2
35 quarters
|
|
6
Apple
AAPL
$5.18T
| $786M | 0.92% |
4,504,192
+1,832,460
| +69% | +$308M |
2020 Q3
6 quarters
|
|
|
7
Advanced Micro Devices
AMD
$876B
| $777M | 0.91% |
+7,107,290
| New | +$848M |
2022 Q1
0 quarters
|
|
8
Atlassian
TEAM
$37.8B
| $777M | 0.91% |
2,643,920
-259,400
| -9% | -$77.5M |
2016 Q2
23 quarters
|
|
9
Zoom
ZM
$29.1B
| $756M | 0.89% |
6,449,306
+2,444,294
| +61% | +$332M |
2020 Q1
8 quarters
|
|
10
Amazon
AMZN
$2.88T
| $675M | 0.79% |
4,141,100
+1,188,000
| +40% | +$184M |
2021 Q4
1 quarter
|
|
|
11
Meta Platforms (Facebook)
META
$1.64T
| $667M | 0.78% |
3,001,000
+2,270,300
| +311% | +$567M |
2021 Q3
2 quarters
|
|
12
Hershey
HSY
$35B
| $663M | 0.78% |
3,060,267
-124,119
| -4% | -$25.2M |
2013 Q2
35 quarters
|
|
13
Moderna
MRNA
$90.4B
| $658M | 0.77% |
3,818,180
+1,984,458
| +108% | +$334M |
2020 Q4
5 quarters
|
|
14
Franco-Nevada
FNV
$47.7B
| $650M | 0.76% |
4,073,503
-49,400
| -1% | -$7.11M |
2014 Q1
32 quarters
|
|
15
Alphabet (Google) Class A
GOOGL
$3.64T
| $633M | 0.74% |
4,552,960
+360,000
| +9% | +$48.9M |
2018 Q3
14 quarters
|
|
16
McDonald's
MCD
$192B
| $626M | 0.73% |
2,531,400
+776,419
| +44% | +$193M |
2020 Q4
5 quarters
|
|
17
Molina Healthcare
MOH
$10.9B
| $605M | 0.71% |
1,813,615
-97,700
| -5% | -$30.1M |
2013 Q2
35 quarters
|
|
18
Airbnb
ABNB
$110B
| $585M | 0.69% |
3,403,767
-184,171
| -5% | -$29.3M |
2021 Q2
3 quarters
|
|
|
19
Home Depot
HD
$348B
| $564M | 0.66% |
+1,882,619
| New | +$653M |
2022 Q1
0 quarters
|
|
20
Monster Beverage
MNST
$90.9B
| $562M | 0.66% |
28,112,240
+2,126,000
| +8% | +$44.6M |
2014 Q1
32 quarters
|
|
21
Verizon
VZ
$192B
| $540M | 0.63% |
10,604,493
+4,756,222
| +81% | +$252M |
2021 Q1
4 quarters
|
|
22
ExxonMobil
XOM
$696B
| $532M | 0.62% |
6,444,764
+131,410
| +2% | +$10.2M |
2021 Q1
4 quarters
|
|
23
United Therapeutics
UTHR
$25.2B
| $496M | 0.58% |
2,765,213
-151,978
| -5% | -$29M |
2013 Q2
35 quarters
|
|
|
ABMD
24
DELISTED
Abiomed Inc
ABMD
| $468M | 0.55% |
1,414,200
-37,100
| -3% | -$11.4M |
2015 Q1
28 quarters
|
|
25
Vodafone
VOD
$35.6B
| $458M | 0.54% |
27,537,932
+1,487,100
| +6% | +$25.4M |
2015 Q3
26 quarters
|
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 821 new positions and adding to 1,554 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 821 new positions and closed 649 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.